SS
RCEL icon

Sunbelt Securities’s Avita Medical RCEL Stock Holding History

Sunbelt Securities’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11 Buy
+3
New +$13 ﹤0.01% 2917

Other funds holding RCEL

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Sunbelt Securities's RCEL Position: Q1 2026 in Review

Sunbelt Securities opened a new position in Avita Medical (RCEL) in Q1 2026: 3 shares worth $11. The stake represents ﹤0.01% of the portfolio and ranks #2917 among its holdings.

79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

  • Sunbelt Securities held 3 shares of Avita Medical worth $11 as of Q1 2026.
  • Avita Medical was a new Sunbelt Securities position in Q1 2026.
  • Avita Medical made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2917 holding.
  • 79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.